(19)
(11) EP 1 141 357 A1

(12)

(43) Date of publication:
10.10.2001 Bulletin 2001/41

(21) Application number: 00902591.7

(22) Date of filing: 14.01.2000
(51) International Patent Classification (IPC)7: C12N 15/85, C07K 14/075, C12N 5/10, C12N 15/34, A61K 48/00
(86) International application number:
PCT/EP0000/265
(87) International publication number:
WO 0042/208 (20.07.2000 Gazette 2000/29)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 14.01.1999 US 115920 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1230 Wien (AT)

    AT 
  • THE SCRIPPS RESEARCH INSTITUTE
    La Jolla, CA 92037 (US)

    AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE 

(72) Inventors:
  • NEMEROW, Glen, Robert
    Encinitas, CA 92024 (US)
  • VON SEGGERN, Daniel, J.
    San Diego, CA 92122 (US)
  • HALLENBECK, Paul, L.
    Gaithersburg, MD 20882 (US)
  • STEVENSON, Susan, C.
    Frederick, MD 21701 (US)
  • SKRIPCHENKO, Yelena
    Gaithersburg, MD 20878 (US)

(74) Representative: Becker, Konrad 
Novartis AGGeistiges Eigentum KonzernPatent- und Markenabteilung CHPostfach
4002 Basel
4002 Basel (CH)

   


(54) ADENOVIRUS VECTORS, PACKAGING CELL LINES, COMPOSITIONS, AND METHODS FOR PREPARATION AND USE